Home › Chronic Myeloid Leukemia › Washington › Seattle
Chronic Myeloid Leukemia clinical trials in Seattle, WA
11 studies for Chronic Myeloid Leukemia are looking for participants at sites in and around Seattle (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
RecruitingPhase 2
- Seattle Childrens Hospital, Seattle
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
- and 1 more
Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
RecruitingPhase 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
TGRX-678 US Phase I for Chronic Myelogenous Leukemia Patients
RecruitingPhase 1
- Fred Hutchinson Cancer Center, Seattle
A Clinical Study of MK-4208/TERN-701 in Participants With Chronic Myeloid Leukemia (CML) (MK-4208-003/Tern701-1012/CARDINAL)
RecruitingPhase 1/2
- Fred Hutchinson Cancer Center, Seattle
Study of Olverembatinib (HQP1351) in Patients With CML-CP
RecruitingPhase 3
- Ascentage Investigative Site #1806, Seattle
- Ascentage Investigative Site #1510, Seattle
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecruitingObservational study
- Fred Hutchinson Cancer Research Center, Seattle
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
RecruitingPhase 2Healthy volunteers welcome
- Fred Hutch/University of Washington Cancer Consortium, Seattle
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
RecruitingPhase 1
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
RecruitingPhase 2
- Fred Hutchinson Cancer Center, Seattle
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
RecruitingPhase 1
- Fred Hutchinson Cancer Research Center, Seattle
About Chronic Myeloid Leukemia
Chronic myeloid leukemia (CML) is a cancer of the white blood cells. It usually affects older adults. Learn about symptoms, genetics, and treatment.
More about Chronic Myeloid Leukemia on MedlinePlus
Chronic Myeloid Leukemia trials in other cities
- Houston, TX18 studies
- New York City, NY10 studies
- Portland, OR7 studies
- Baldwin Park, CA7 studies
- Chicago, IL7 studies
- Detroit, MI6 studies
- Birmingham, AL6 studies
- Philadelphia, PA6 studies
- St. Louis, MO6 studies
- Milwaukee, WI5 studies
- Nashville, TN5 studies
- Atlanta, GA5 studies
Other studies in Seattle
- Non-Small Cell Lung Cancer55 studies
- Cancer (all types)48 studies
- Prostate Cancer45 studies
- Acute Myeloid Leukemia40 studies
- Metastatic Cancer39 studies
- Breast Cancer37 studies
- Colorectal Cancer35 studies
- Lung Cancer34 studies
- Ovarian Cancer29 studies
- Pancreatic Cancer22 studies
- Multiple Myeloma22 studies
- Acute Lymphoblastic Leukemia22 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.